Welcome to Innovacell Biotechnologie AG
Innovacell Biotechnologie AG is an innovative biotechnology company that develops personalized cell therapies for treatment of incontinence. Innovacell is running multinational clinical trials for its two ‘tissue-engineered’ products in development, ICES13 and ICEF15. Using Innovacell’s innovative ‘ultrasound-guided’ injector, patients benefit from a minimally invasive surgery. More than 500 patients have been treated since 2002.
Cures for Incontinence
News
Termine & Events: 2011-10-31Innovacell presents at congress in London Innovacell Biotechnologie AG today has announced to be one of the presenters at the upcoming Commercial Translation of Regenerative Medicine Congress in London from November 14th - 16th. read more »